(Q57253418)
Statements
Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo (English)
Inessa Schwab
Sidonia Mihai
Michael Kasperkiewicz
scientific article published on 07 March 2014